about
Neuroprotective effects of edaravone-administration on 6-OHDA-treated dopaminergic neuronsPermeating the blood brain barrier and abrogating the inflammation in stroke: implications for stroke therapyDietary supplementations as neuroprotective therapies: focus on NT-020 diet benefits in a rat model of strokeRecent preclinical evidence advancing cell therapy for Alzheimer's disease.Regenerative medicine for Parkinson's disease.Stem cell therapy for abrogating stroke-induced neuroinflammation and relevant secondary cell death mechanisms.Preliminary Reports of Stereotaxic Stem Cell Transplants in Chronic Stroke Patients.Mannitol facilitates neurotrophic factor up-regulation and behavioural recovery in neonatal hypoxic-ischaemic rats with human umbilical cord blood grafts.Cell Therapy for Parkinson's Disease.Endogenous repair mechanisms enhanced in Parkinson's disease following stem cell therapy
P2860
Q21262040-15690551-33F8-472E-8419-DD3980866162Q26865517-9033CC87-D067-4639-861A-749E7241DC5DQ26991784-5A1A9023-AFC8-4F1C-A55B-C9F062BDAF11Q38024220-5E004477-8B50-4075-9A8B-D4B88DA12142Q38369065-05CED8B5-4332-4B7A-B824-FA1020CA3E84Q39457984-AB7577AF-4E11-4D6D-9BDA-074D91523040Q41653901-3FC3840C-A474-4423-AC4A-A8DD25B24864Q42914219-A4900F00-0A6B-4EBD-B279-80A6F1DBD29EQ45740164-E297425B-7992-42EE-B610-D66CDA7E3610Q57153012-868F25CB-2B8A-4E37-A400-59F75776B5B1
P2860
description
1999 nî lūn-bûn
@nan
1999 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Neural transplantation for neurodegenerative disorders.
@ast
Neural transplantation for neurodegenerative disorders.
@en
type
label
Neural transplantation for neurodegenerative disorders.
@ast
Neural transplantation for neurodegenerative disorders.
@en
prefLabel
Neural transplantation for neurodegenerative disorders.
@ast
Neural transplantation for neurodegenerative disorders.
@en
P2093
P1433
P1476
Neural transplantation for neurodegenerative disorders.
@en
P2093
C V Borlongan
P R Sanberg
T B Freeman
P304
P407
P478
353 Suppl 1
P577
1999-04-01T00:00:00Z